- Notice
- Society for the Study of Super-Different Fields
Osaka Conference of the Association of Hyperdifferent Fields] Academia, Industry is Calling! /April 24, 2021 from 16:30
2021.04.14
A panel discussion, "Academia, Industry is Calling!" will be held within the Osaka Conference 2021 (Saturday, April 24, 2021) of the Society of Transdisciplinary Research, organized by RIVANES. (session partner: Kobe Medical Industry Development Organization).
In these uncertain times, academia's research capabilities should be utilized in industry. In Japan, however, there is still a large gap between academia and industry, and the influx of human resources from academia to industry has been a failure.
In this session, therefore, a large company with strengths in R&D, a startup, and a startup supporter will discuss specifically what can be done when doctoral personnel join their company or the community they are supporting, in order to envision the world view after human resource mobility occurs. The three people who will take on this topic are Dr. Nakao, President and Representative Director of Takara Bio, which is active globally in the life science field, from research support to industrial application of research results and clinical-related business, and Dr. Yanagisawa, President and Representative Director of CellFiber, a startup that focuses on cell engineering as its core technology, after obtaining his doctoral degree, D., who joined Cell Fiber, a startup with cell engineering as its core technology; and LuidaBio's CEO, Mr. Kono, who exited a biomedical venture based on technology from his graduate laboratory and is now providing hands-on support to other ventures in the same field. D. in the U.S. and joined LIVERNESS, and is a regular observer of trends in academia around the world.
In addition, the session will also introduce examples of doctoral candidates in the Kobe Biomedical Innovation Cluster community, where session partner Kobe Biomedical Innovation Cluster Promotion Organization serves as a core support organization, as well as future human resource mobility models.
We will have a program of discussions among researchers, start-ups, and large companies from a variety of perspectives, not limited to the themes of this session.
Academia, industry is calling!
Date: Saturday, April 24, 2021, 16:30-17:30
Location:Maruzen Intec Arena Osaka (3-1-40 Tanaka, Minato-ku, Osaka, 552-0005, Japan (in Hachimanya Park)
Details:https://hic.lne.st/conference/hic2021/
speaker
Takara Bio Inc.
President and Representative Director
Koichi Nakao
Graduated from Kyoto University's Faculty of Agriculture in 1985 and joined Hozo Shuzo Co., Ltd. in 2002, and became a director of Takara Bio Co., Ltd. when Hozo Shuzo's biotechnology business was spun off. He has also been a director of the Kinki Bioindustry Promotion Conference since 2004, a director of the Bioindustry Association of Japan since 2009, a director of the Advanced Technology Research Institute of Kyoto since 2009, and a director of the Shiga Bio Industry Promotion Organization since 2013.The following is a list of the most common problems with the
LuidaBio LLC
senior partner
Yusuke Kono
Co-founded JITSUBO in 2005 and grew it into a drug development company while changing the business model several times, leading the sale to Sosei Group Inc. in 2014. LuidaBio LLC in 2018. In 2018, he co-founded Phimex, Inc. from Takeda Pharmaceuticals, Inc. and saw it through to completion of its Series A financing, retiring from the company. Currently, he is working with university researchers, bio-venture companies, and investors to create a mechanism to gather information, people, goods, and money according to the business stage. He also serves as a producer for the Ministry of Education, Culture, Sports, Science and Technology's Regional Ecosystem Formation Program in Kobe.
Cell Fiber Corporation
Representative Director and President
Yu Yanagisawa
D. (Engineering). received his degree in Hydrogel and Functional Polymer Research from the University of Tokyo in December 2017. joined Cell Fiber in February 2018 and was appointed as Director. in 2019, he was appointed as Representative Director and President to oversee business development and research and development. He is working on creating a new bioprocess business.
.
Leave a Nest Co., Ltd.
Director, Global Bridge Institute
Ryuta Takeda(Ryuta Takeda)
D. in 2011 after studying the structure of plant pathogens at Ohio State University. D. in 2011. After joining RIVANES, he served as the General Manager of the Human Resources Development Division and the General Manager of the International Development Division before assuming his current position as the Director of the Global Bridge Institute and Director. He has contributed to the overseas strategies of each of RIVANES' businesses, especially the development of TECH PLANTER, which discovers and nurtures university-originated deep technologies, in 10 countries. He has a wide network of key players in the overseas venture ecosystem and is currently involved in creating a place where deep issues in Southeast Asia can be solved with Japanese science and technology.
English 
Japanese